131 related articles for article (PubMed ID: 11978156)
1. Lansoprazole-induced thrombocytopenia.
Zlabek JA; Anderson CG
Ann Pharmacother; 2002 May; 36(5):809-11. PubMed ID: 11978156
[TBL] [Abstract][Full Text] [Related]
2. [A case of hemolysis induced by lansoprazole].
Suzuki T; Hayashi T; Nonaka Y; Hirano M; Nomura T; Miyazawa I; Ishikawa F; Kakiuchi T
Rinsho Ketsueki; 1996 Dec; 37(12):1389-94. PubMed ID: 8997127
[TBL] [Abstract][Full Text] [Related]
3. A trial of lansoprazole in refractory gastric ulcer.
van Rensburg CJ; Louw JA; Girdwood AH; Simjee AE; Marks IN
Aliment Pharmacol Ther; 1996 Jun; 10(3):381-6. PubMed ID: 8791967
[TBL] [Abstract][Full Text] [Related]
4. [Lansoprazole--profile of a new proton pump inhibitor].
Seifert E
Leber Magen Darm; 1994 Mar; 24(2):66-8, 71. PubMed ID: 8196467
[TBL] [Abstract][Full Text] [Related]
5. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
Florent C
Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
[TBL] [Abstract][Full Text] [Related]
6. [Effectiveness and safety of lansoprazole in the treatment of peptic ulcer].
Ramón Nogueira J; Esquivel Ayanegui F; Esquivel Rodríguez F; Sáenz V; Santoyo R
Rev Gastroenterol Mex; 1996; 61(4):314-9. PubMed ID: 9072782
[TBL] [Abstract][Full Text] [Related]
7. Comparison of once daily doses of lansoprazole (15, 30, and 60 mg) and placebo in patients with gastric ulcer.
Avner DL; Movva R; Nelson KJ; McFarland M; Berry W; Erfling W
Am J Gastroenterol; 1995 Aug; 90(8):1289-94. PubMed ID: 7639232
[TBL] [Abstract][Full Text] [Related]
8. Effects of long-term treatment with lansoprazole and omeprazole on serum gastrin and the fundic mucosa.
Arroyo Villarino MT; Lanas Arbeloa A; Esteva Díaz F; Ortego Fernández de Retana J; Sainz Samitier R
Rev Esp Enferm Dig; 1997 May; 89(5):347-56. PubMed ID: 9190140
[TBL] [Abstract][Full Text] [Related]
9. Double-blind comparison of lansoprazole 15 mg, lansoprazole 30 mg, and placebo in the maintenance of healed gastric ulcer.
Kovacs TO; Campbell D; Haber M; Rose P; Jennings DE; Richter J
Dig Dis Sci; 1998 Apr; 43(4):779-85. PubMed ID: 9558034
[TBL] [Abstract][Full Text] [Related]
10. [Double-blind controlled-clinical trials of lansoprazole in the treatment of peptic ulcer].
Ogawa N
Nihon Rinsho; 1992 Jan; 50(1):68-73. PubMed ID: 1347332
[TBL] [Abstract][Full Text] [Related]
11. Possible lansoprazole-induced eosinophilic syndrome.
Smith JD; Chang KL; Gums JG
Ann Pharmacother; 1998 Feb; 32(2):196-200. PubMed ID: 9496405
[TBL] [Abstract][Full Text] [Related]
12. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
Goldstein JL; Huang B; Amer F; Christopoulos NG
Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
[TBL] [Abstract][Full Text] [Related]
13. Intravenous administration of lansoprazole: a preliminary study of dose ranging and efficacy in upper gastrointestinal bleeding.
Aoki T
Aliment Pharmacol Ther; 1995; 9 Suppl 1():51-7. PubMed ID: 7495944
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of lansoprazole (30 mg) and omeprazole (20 mg) in the treatment of duodenal ulcer. A multicenter double-blind comparative trial].
Petite JP; Slama JL; Licht H; Lemerez M; Coste T; Andrieu J; Grimaud JC; Julien H; Dupuis J; Sallerin V
Gastroenterol Clin Biol; 1993; 17(5):334-40. PubMed ID: 8349067
[TBL] [Abstract][Full Text] [Related]
15. Delayed-release lansoprazole plus naproxen.
Curran MP; Wellington K
Drugs; 2004; 64(17):1915-9; discussion 1920-1. PubMed ID: 15329041
[TBL] [Abstract][Full Text] [Related]
16. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
[TBL] [Abstract][Full Text] [Related]
17. [Lansoprazole-induced hepatitis].
Viana de Miguel C; Alvarez García M; Sánchez Sánchez A; Carvajal García-Pando A
Med Clin (Barc); 1997 Apr; 108(15):599. PubMed ID: 9280798
[No Abstract] [Full Text] [Related]
18. Lansoprazole versus omeprazole in the treatment of reflux esophagitis.
Vcev A; Stimac D; Vceva A; Rubinić M; Ivandić A; Ivanis N; Horvat D; Volarić M; Karner I
Acta Med Croatica; 1997; 51(3):171-4. PubMed ID: 9248117
[TBL] [Abstract][Full Text] [Related]
19. [Lansoprazole-induced gynecomastia].
Comas A; Salgueiro E; Hidalgo A
Med Clin (Barc); 2000 Mar; 114(10):397. PubMed ID: 10786353
[No Abstract] [Full Text] [Related]
20. Haemorrhagic gastritis and bleeding following rofecoxib administration.
Tuccori M; Martini G; Giustini SE; Salvetti A; Blandizzi C; Del Tacca M
Clin Exp Rheumatol; 2005; 23(5):727-8. PubMed ID: 16173261
[No Abstract] [Full Text] [Related]
[Next] [New Search]
